ORLY reports better-than-expected Q4 results and expects 2025 revenues in the range of $17.4-$17.7 billion compared with $16.7 billion reported in...

GM reports better-than-expected results for Q4 2024 and expects full-year 2025 adjusted EBIT in the range of $13.7-$15.7 billion, up from $14.9...

CNH reports lower-than-expected Q4 results and expects 2025 Agriculture & Construction sales to decline 13-18% and 5-10%, respectively.

UGI's fiscal first-quarter earnings are better than expected. The company continues to invest systematically to strengthen the natural gas business.

SR's first-quarter fiscal 2025 earnings are lower than expected, and revenues decrease year over year.

STERIS' third-quarter fiscal 2025 results reflect strong growth momentum in Healthcare and AST revenues. The lowered revenue guidance for fiscal 2025...

UTI's first-quarter fiscal 2025 results indicate growth in new student starts and average full-time active students at UTI and Concorde.

TTE's fourth-quarter earnings are better than expected. The company continues to expand its clean power generation and efficiently serves customers.

Novo Nordisk stock gains as it reports better-than-expected fourth-quarter 2024 results driven by strong sales of Diabetes and Obesity care products.

LH delivers better-than-expected revenues and earnings in the fourth quarter of 2024.